IL18 and neoplasm: This comparative study demonstrates for the first time that TCR bypass stimulation i.e., γδ T cells stimulated solely with combined IL-2/IL-12/IL-18 is enough to induce γδ T cells that exhibit the same efficiency in anti-tumor activity as their counterparts after TCR crosslinking.